Camber Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-424,600
Closed -$1.88M 46
2022
Q2
$1.88M Buy
+424,600
New +$1.88M 0.08% 38
2020
Q2
Sell
-2,500,000
Closed -$7.65M 35
2020
Q1
$7.65M Buy
+2,500,000
New +$7.65M 0.46% 27